Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 872 All time
- Disclosed funding
- $32.9B 788 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| HE HVR EnergyCompany profile HVR Energy develops and operates modular hydrogen refuelling stations and a network for professional fleets and hydrogen-powered light-duty vehicles. Its compact station design can be installed at existing sites and expanded in stages as demand grows, lowering the infrastructure commitment required to serve early hydrogen mobility markets. HVR Energy develops and operates modular hydrogen refuelling stations and a network for professional fleets and hydrogen-powered light-duty vehicles. Its compact station design can be installed at existing sites and expanded in stages as demand grows, lowering the infrastructure commitment required to serve early hydrogen mobility markets. | €20M | Series A | Mobility | Spain | Investors | |
| A AquaCompany profile Aqua gives wealth managers and fund sponsors one platform to launch and manage alternative investments. Aqua gives wealth managers and fund sponsors one platform to launch and manage alternative investments. | $15M | Series A | Fintech | United States | Investors | |
| A AllogeneticsCompany profile Allogenetics is developing a one-time ex vivo gene therapy that modifies donor organs before transplantation, aiming to reduce immune rejection without suppressing the recipient’s immune system. Its lead ALG-115 program is advancing through preclinical and IND-enabling work for lung transplantation. Allogenetics is developing a one-time ex vivo gene therapy that modifies donor organs before transplantation, aiming to reduce immune rejection without suppressing the recipient’s immune system. Its lead ALG-115 program is advancing through preclinical and IND-enabling work for lung transplantation. | €3.8M | Pre-Series ASeries A | Biotech | Germany | Investors | |
| TT TwoStep TherapeuticsCompany profile A peptide-targeting platform is advancing conjugate and radioligand therapies for solid tumors. A peptide-targeting platform is advancing conjugate and radioligand therapies for solid tumors. | $62.5M | Series A | Biotech | United States | Investors | |
| Z ZeroRiskCompany profile A cyber-risk platform for banks and payment providers to monitor merchant portfolios, guide remediation and manage compliance. A cyber-risk platform for banks and payment providers to monitor merchant portfolios, guide remediation and manage compliance. | $10M | Series A | Cybersecurity | Ireland | Investors | |
| T TheaterCompany profile Theater is a digital-first fashion and lifestyle brand selling footwear, bags, clothing accessories and perfumes. Theater is a digital-first fashion and lifestyle brand selling footwear, bags, clothing accessories and perfumes. | ₹750M | Series A | Consumer | India | Investors | |
| L LatitudeCompany profile Provides payment infrastructure connecting stablecoins with local currencies and payment networks. Provides payment infrastructure connecting stablecoins with local currencies and payment networks. | $35M | Series A | Fintech | United States | Investors | |
| AT Albatross Technology, Inc.Company profile A developer of floating vertical-axis wind turbines for offshore power generation in deep water. A developer of floating vertical-axis wind turbines for offshore power generation in deep water. | ¥250M | Pre-Series BSeries A | Climate tech | Japan | Investors | |
| SO Solstice OncologyCompany profile A clinical-stage immunotherapy company is advancing an engineered CTLA-4 antibody for earlier cancer treatment. A clinical-stage immunotherapy company is advancing an engineered CTLA-4 antibody for earlier cancer treatment. | $225M | Series A | Biotech | United States | Investors | |
| A ActionableCompany profile Predictive customer experience software that connects commerce, customer feedback and operational data to explain KPI changes and help teams act on likely customer behavior. Predictive customer experience software that connects commerce, customer feedback and operational data to explain KPI changes and help teams act on likely customer behavior. | $10M | Series A | Enterprise software | France | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Clueso, Santé, Flai
52rounds0led - 2Andreessen Horowitz (a16z)
Eka Robotics, TypeSafe AI, Sharp Performance
29rounds9led - 3General Catalyst
Baba, Melius, Disha (formerly Curelink)
24rounds1led - 4Lightspeed
Warp Sciences, Zenzap, Avarra
21rounds4led - 5Alumni Ventures
Chariot Claims, RegCell, Inc., Lightfield
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.